Product Code: ETC8537033 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Drug Safety Solutions and Pharmacovigilance Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Drug Safety Solutions and Pharmacovigilance Market - Industry Life Cycle |
3.4 Netherlands Drug Safety Solutions and Pharmacovigilance Market - Porter's Five Forces |
3.5 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Functionality, 2021 & 2031F |
3.8 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Delivery, 2021 & 2031F |
3.9 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Drug Safety Solutions and Pharmacovigilance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Stringent regulations by authorities like the Dutch Healthcare Inspectorate (IGJ) driving the need for robust drug safety solutions |
4.2.2 Increasing focus on patient safety and adverse event reporting leading to higher demand for pharmacovigilance services |
4.2.3 Growing prevalence of chronic diseases and the subsequent rise in drug consumption necessitating enhanced drug safety measures |
4.3 Market Restraints |
4.3.1 High implementation costs associated with advanced pharmacovigilance systems hindering market adoption |
4.3.2 Data privacy concerns and regulatory complexities impacting the implementation of drug safety solutions |
4.3.3 Limited awareness and expertise in pharmacovigilance practices among healthcare professionals in the Netherlands |
5 Netherlands Drug Safety Solutions and Pharmacovigilance Market Trends |
6 Netherlands Drug Safety Solutions and Pharmacovigilance Market, By Types |
6.1 Netherlands Drug Safety Solutions and Pharmacovigilance Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Software, 2021- 2031F |
6.1.4 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market, By Product |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Standard Form, 2021- 2031F |
6.2.3 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Customized Form, 2021- 2031F |
6.3 Netherlands Drug Safety Solutions and Pharmacovigilance Market, By Functionality |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Adverse Event Reporting Software, 2021- 2031F |
6.3.3 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Drug Safety Audits Software, 2021- 2031F |
6.3.4 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Issue Tracking Software, 2021- 2031F |
6.4 Netherlands Drug Safety Solutions and Pharmacovigilance Market, By Delivery |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By On-Premise Delivery Mode, 2021- 2031F |
6.4.3 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By On-Demand/Cloud-Based (SAAS) Delivery Mode, 2021- 2031F |
6.5 Netherlands Drug Safety Solutions and Pharmacovigilance Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Biotechnology and Pharmaceuticals, 2021- 2031F |
6.5.3 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Contract Research Organizations (CROS), 2021- 2031F |
6.5.4 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.5 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By KPOs/BPOs, 2021- 2031F |
6.5.6 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.6 Netherlands Drug Safety Solutions and Pharmacovigilance Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Direct Sales, 2021- 2031F |
6.6.3 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenues & Volume, By Retail Sales, 2021- 2031F |
7 Netherlands Drug Safety Solutions and Pharmacovigilance Market Import-Export Trade Statistics |
7.1 Netherlands Drug Safety Solutions and Pharmacovigilance Market Export to Major Countries |
7.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Imports from Major Countries |
8 Netherlands Drug Safety Solutions and Pharmacovigilance Market Key Performance Indicators |
8.1 Number of adverse event reports processed per month |
8.2 Percentage increase in drug safety compliance among pharmaceutical companies |
8.3 Average time taken to report and investigate adverse drug reactions |
9 Netherlands Drug Safety Solutions and Pharmacovigilance Market - Opportunity Assessment |
9.1 Netherlands Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Product, 2021 & 2031F |
9.3 Netherlands Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Functionality, 2021 & 2031F |
9.4 Netherlands Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Delivery, 2021 & 2031F |
9.5 Netherlands Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Netherlands Drug Safety Solutions and Pharmacovigilance Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Drug Safety Solutions and Pharmacovigilance Market - Competitive Landscape |
10.1 Netherlands Drug Safety Solutions and Pharmacovigilance Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Drug Safety Solutions and Pharmacovigilance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |